PHBBF (Pharmaron Beijing Co) Beginning Cash Position: $122 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PHBBF Pharmaron Beijing Co Ltd PHBBF
92 GF Score
Price $1.93
GF Value $1.79
! 8 Warning Signs
View Full Analysis

What is Pharmaron Beijing Co Beginning Cash Position?

Pharmaron Beijing Co PHBBF 92 Beginning Cash Position is $122 Mil as of Mar. 2026. GuruFocus rates PHBBF with a GF Score™ of 92/100 and a GF Value™ of $1.79. The stock has 8 warning signs investors should review.

Pharmaron Beijing Co's Beginning Cash Position for the quarter that ended in Mar. 2026 was $122 Mil.

Pharmaron Beijing Co's quarterly Beginning Cash Position declined from Sep. 2025 ($170 Mil) to Dec. 2025 ($157 Mil) and declined from Dec. 2025 ($157 Mil) to Mar. 2026 ($122 Mil).

Pharmaron Beijing Co's annual Beginning Cash Position increased from Dec. 2023 ($190 Mil) to Dec. 2024 ($795 Mil) but then declined from Dec. 2024 ($795 Mil) to Dec. 2025 ($230 Mil).

Pharmaron Beijing Co Beginning Cash Position Related Terms

Pharmaron Beijing Co Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Pharmaron Beijing Co's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmaron Beijing Co Beginning Cash Position Chart

Pharmaron Beijing Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 369.58 397.28 190.43 795.13 230.43

Pharmaron Beijing Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 223.88 163.44 169.59 157.02 122.27
PHBBF
92GF Score
Pharmaron Beijing Co Ltd PHBBF
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pharmaron Beijing Co Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $122 Mil mean?
Pharmaron Beijing Co (PHBBF) has a Beginning Cash Position of $122 Mil as of Mar. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Pharmaron Beijing Co and its competitors.
Is Pharmaron Beijing Co's Beginning Cash Position too high?
Pharmaron Beijing Co's current Beginning Cash Position is $122 Mil. Overall, Pharmaron Beijing Co has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does Pharmaron Beijing Co's Beginning Cash Position compare to VRTX and REGN?
Pharmaron Beijing Co's Beginning Cash Position of $122 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Biotechnology company?
A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Pharmaron Beijing Co and its competitors. Pharmaron Beijing Co's current Beginning Cash Position is $122 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmaron Beijing Co stock overvalued right now?
Pharmaron Beijing Co (PHBBF) has a current Beginning Cash Position of $122 Mil. The stock's GF Value™ is $1.79, compared to a current price of $1.93 — trading 7.8% above its estimated fair value. The current Beginning Cash Position is $122 Mil. Pharmaron Beijing Co's overall GF Score™ is 92/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Pharmaron Beijing Co (PHBBF), the current Beginning Cash Position is $122 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pharmaron Beijing Co (PHBBF) Overvalued in 2026?

Based on GuruFocus' analysis, Pharmaron Beijing Co stock appears to be overvalued. The current stock price of $1.93 is trading 7.8% above its estimated GF Value™ of $1.79.

Key valuation signals for PHBBF:

  • Beginning Cash Position: $122 Mil
  • GF Value™: $1.79 vs. price of $1.93 (7.8% above fair value)
  • GF Score™: 92/100 with 8 warning signs

No single metric tells the full story. See the PHBBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pharmaron Beijing Co Business Description

Address 6 Tai-He Road, 8th Floor, Block 1, Beijing Economic Technological Development Area, Beijing, CHN, 100176
Pharmaron Beijing Co Ltd is a research and development service company supporting the life science industry. The company offers drug research and development service capabilities, ranging from synthetic, medicinal, and analytical chemistry, biology, DMPK, pharmacology, drug safety assessment, radiochemistry, and isotopically labelled metabolism, chemical and pharmaceutical development to clinical development. Its operating segment includes Laboratory services; CMC (small molecule CDMO) services, Clinical development services, and biologics and CGT services. It generates maximum revenue from the Laboratory services segment.
92GF Score

Get the complete analysis for PHBBF

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.93
Price
$1.79
GF Value